Clariane Shares Plunge 20% in a Year, Breaking a Key Support
Clariane's stock experienced a sharp decline this Thursday, March 26, trading at 3.366 euros midday, down 2.55% from the previous day's close. This downturn is part of a marked bearish trend, with the stock losing over 11% in the past seven days. The CAC 40 is also down during the session, at 7,778.33 points (-0.87%), as is the SBF 120, which is down 0.92%.
During the session, Clariane's stock price broke below the support threshold of 3.45 euros, a level that matched the previous day's close. This downward breach is a negative technical signal, especially since the stock is now trading well below its 20-day (3.78 euros), 50-day (3.85 euros), and 200-day (4.16 euros) moving averages. The growing gap from these benchmarks indicates a bearish momentum that has been building for several weeks. The RSI, an indicator measuring the speed and magnitude of price movements, stands at 33, very close to the conventionally set oversold zone at 30. This level indicates that selling pressure heavily dominates the market. The next technical resistance is at 4.07 euros, over 20% above the current price, highlighting the significant ground to cover for a potential bullish reversal.
Three-Month Decline Reaches 11.47%, Annual Underperformance at 20.27%
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Over three months, the decline reaches 11.47%, while the annual underperformance amounts to 20.27%. This steady erosion places Clariane among the struggling stocks in the Parisian market. A negative beta of -0.30 also indicates that the stock tends to move inversely to its reference index, making it an atypical profile within the market. Regarding the schedule, the group specializing in retirement homes and health services is set to publish its first-quarter 2026 revenue on April 23. This date will be followed by the annual general meeting scheduled for May 12. These events will provide investors with concrete elements to assess the operational trajectory of the group after several quarters of pressure on the stock. Until then, the monthly volatility, measured at 15.11, remains at a significant level, reflecting still erratic price movements in the recent period.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Contexte
Period
Period: 1T2026
Key reported figures
Revenue: 1336M€
Guidance from the release
Avec une croissance organique de 4,9 %, le premier trimestre 2026 s’inscrit pleinement dans la dynamique.
Le chiffre d’affaires au 31 mars 2026 s’établit à €1 336m, en progression de +4,9%.
Risks mentioned
Impact des cessions intervenues en 2025 dans le cadre du plan de renforcement.
Risque lié aux conditions de marché futures.
Effets des défis réglementaires dans le secteur.
Opportunities identified
Lancement d'une obligation senior de €500m à échéance 2031.
Nouvelle dynamiqueprix/volume grâce aux mesures d’adaptation mises en place.
Engagement fort des collaborateurs pour atteindre les objectifs opérationnels.
Les informations présentées dans cet article sont fournies à titre purement indicatif et ne constituent en aucun cas une recommandation d'investissement, une incitation à acheter ou vendre un actif financier, ni un conseil en placement. Le lecteur est invité à réaliser ses propres recherches avant toute décision.
Les investissements en bourse comportent des risques, notamment de perte en capital. La performance passée d'un actif ou d'un marché ne présage en rien de ses performances futures. Toute décision d'investissement doit être prise en tenant compte de votre situation financière personnelle, de vos objectifs et de votre tolérance au risque.